A-Alpha Bio Companies

A-Alpha Bio is an organization that utilizes synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions. They provide cell-based tools for quantitative and high-throughput measurements of protein interactions, which accelerates target discovery, library screening, and preclinical drug characterization. Their proprietary AlphaSeq technology allows them to map protein-protein interactions at a high scale and resolution, identifying and quantifying interactions between thousands of protein pairs simultaneously. By providing detailed maps of protein interactions, A-Alpha Bio aids in the identification of potential drug targets and the understanding of disease mechanisms, streamlining the process of discovering new therapeutics.
Technology: Companies
Industry: AI R&D Pharma (DPI)
Headquarters: Seattle, Washington, United States
Founded Date: 2017
Employees Number: 56

Visit Website
contact@aalphabio.com
https://twitter.com/AAlphaBio
Register and Claim Ownership